Product Information
PHENOBARBITAL 16.2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0483 per EA under NDC 16571067101. Its NADAC has been published 256 times since Aug 4, 2021.
Strength
16.2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571067101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/1/2020
Price Statistics
The NADAC for PHENOBARBITAL 16.2 MG TABLET has been published 256 times since Aug 4, 2021, and over the history we have for it it has declined 80.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0483 per EA |
|---|---|
| All-time high | $0.2730 (Sep 14, 2022) |
| All-time low | $0.0483 (Jun 17, 2026) |
| 52-week high | $0.0947 |
| 52-week low | $0.0483 |
| Median price | $0.1606 |
| Average price | $0.1493 |
| Largest weekly change | +149.4% (Jun 19, 2024) |
| Weeks tracked | 256 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 16.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 16.2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0483 per EA (NDC 16571067101), effective Jun 24, 2026.
How has the price of PHENOBARBITAL 16.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 16.2 MG TABLET has declined 80.7%. It has been tracked across 256 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 16.2 MG TABLET?
Since Aug 4, 2021, the NADAC for PHENOBARBITAL 16.2 MG TABLET has ranged from a low of $0.0483 (Jun 17, 2026) to a high of $0.2730 (Sep 14, 2022), with a median of $0.1606 per EA.
Are there cheaper alternatives to PHENOBARBITAL 16.2 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as PHENOBARBITAL 16.2 MG TABLET, but none are currently priced below it.
Who manufactures PHENOBARBITAL 16.2 MG TABLET?
PHENOBARBITAL 16.2 MG TABLET (NDC 16571067101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification